In NAFLD patients, elevated serum and hepatic mRNA levels of CCL2 increase the recruitment of CCR2-positive bone marrow-derived monocytes into the liver, resulting in further hepatic inflammation, fibrosis, and steatosis [13,14,15]. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.